BFM 89.9

HIGHLIGHTS  GE15
Podcast  >  Marketplace  >  The Marketplace  >  Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center

28-Nov-22 15:45

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  managing diseasemedical advances

Tags:  sunway medical centerlung cancer


Share this podcast




Play / Pause

Listen now : BFM 89.9 -- The Business Station

Today’s Shows